IBR

Company Overview

Snapshot

Founded in March 1995, IBR operates with 11–50 employees. The company was acquired by Frutarom in February 2018, marking a significant milestone in its trajectory.

Business overview

IBR develops proprietary technological product platforms and intellectual property to create natural active ingredients for the beauty and wellness industries. The company markets and sells its products, including IBR-ProPhyDerm and PhytoflORAL, through a channel distribution network of regionally specialized distributors. IBR operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Cosmetic Materials, serving the global cosmetics market.

Strategic signal

In February 2018, IBR was acquired by Frutarom for $21 million, as reported by Globes. This acquisition signals a strategic consolidation within the natural ingredients market, validating IBR's technological product platforms and intellectual property in the beauty and wellness industries. For investors, this event highlights the value placed on specialized natural active ingredients and the potential for exits in this niche market.

Company Intelligence Q&A

What is IBR's primary focus?

IBR develops proprietary technological product platforms and intellectual property to create natural active ingredients for the beauty and wellness industries.

When was IBR founded?

IBR was founded in March 1995.

What is the status of IBR?

IBR was acquired by Frutarom in February 2018 and is currently inactive.

Which markets does IBR serve?

IBR serves the global market, with a focus on Israel and Asia, distributing its products through a network of specialized distributors.

What are some of IBR's key products?

IBR's product portfolio includes IBR-ProPhyDerm and PhytoflORAL